Gdf2026 Common Manufacturing Deficiencies For Complex Dosage Forms

Summary

This session offered a case study in which the objective was to analyze and categorize the ten most This session examined the most frequently cited microbiology This presentation discussed the role of the Maximum Daily This session provided a quality perspective of CDER-led drug device combination products with a focus on parenteral drug ... The ICH M13A guideline provides a framework for classifying drug products as high risk or low risk, based on biopharmaceutical ... This session discussed commonly used control strategies in drug applications and inspectional findings for lyophilized drug ... This presentation focused on strategies to demonstrate bioequivalence of products reformulated due to nitrosamine concerns. This premier event brings together FDA subject matter experts from every aspect of the pre-ANDA and ANDA assessment ... FDA discusses considerations in assessing generic drug products of oral This webinar provided an in-depth look into the draft guidance and explain the ICH EWG's current scientific thinking, and provide ...